Oculis Holding AG (OCS) Tax Provisions (2022 - 2026)
Oculis Holding AG's (OCS) quarterly Tax Provisions came in at $125146.5 in Q1 2026, up 1707.38% year-on-year from $6924.2 in Q1 2025, and up 100.12% quarter-over-quarter from -$102.4 million in Q4 2025.
Oculis Holding AG (OCS) Tax Provisions (2022 - 2026) Analysis & Trends
Oculis Holding AG's Tax Provisions history runs 5 years deep, the most recent figure standing at $125146.5 for Q1 2026.
- On a quarterly basis, Tax Provisions rose 1707.38% year-over-year to $125146.5 in Q1 2026; TTM through Mar 2026 was -$118.5 million, a 476.59% decrease from a year earlier, with the FY2025 full-year figure at $224339.9, up 23.35% from the prior year.
- Tax Provisions improved to $125146.5 in Q1 2026 per OCS's latest filing, from -$102.4 million in the prior quarter.
- Across five years, Tax Provisions topped out at $271682.2 in Q4 2024 and bottomed at -$102.4 million in Q4 2025.
- The 5-year median for Tax Provisions is -$20479.8 (2024), against an average of -$8.7 million.
- Across the five-year window, Tax Provisions soared 2213.88% in 2023 and slumped 37777.55% in 2025, its largest moves.
- Year by year, Tax Provisions stood at $14532.3 in 2022, then increased by 0.85% to $14655.6 in 2023, then surged by 1753.78% to $271682.2 in 2024, then slumped by 37777.55% to -$102.4 million in 2025, then jumped by 100.12% to $125146.5 in 2026.
- Per Business Quant, the three latest OCS Tax Provisions figures stand at $125146.5 (Q1 2026), -$102.4 million (Q4 2025), and -$16.3 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 15.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125,146.46 |
| Dec 31, 2025 | -102.36 Mn |
| Sep 30, 2025 | -16.25 Mn |
| Jun 30, 2025 | 28,989.37 |
| Mar 31, 2025 | -7,785.75 |
| Dec 31, 2024 | 271,682.20 |
| Sep 30, 2024 | -20.78 Mn |
| Jun 30, 2024 | -33,173.80 |
| Mar 31, 2024 | -34,370.47 |
| Dec 31, 2023 | 14,655.61 |
| Sep 30, 2023 | 131,329.70 |
| Jun 30, 2023 | -126,788.01 |
| Mar 31, 2023 | -134,064.16 |
| Dec 31, 2022 | 14,532.31 |
| Sep 30, 2022 | -6,212.74 |
| Jun 30, 2022 | -43,608.31 |